Happy gut, happy kidneys? Restoration of gut microbiome ameliorates acute and chronic kidney disease
- PMID: 34614404
- PMCID: PMC8994854
- DOI: 10.1016/j.cmet.2021.08.019
Happy gut, happy kidneys? Restoration of gut microbiome ameliorates acute and chronic kidney disease
Abstract
In a new study, Zhu et al. (2021) show that mitigating dysbiosis by the probiotic L. casei Zhang reduces kidney inflammation via restoring short-chain fatty acid-producing gut microbiome and nicotinamide metabolism. These findings shed light on the underlying mechanisms of probiotics in treating human kidney diseases.
Published by Elsevier Inc.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Figures
Comment on
-
The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease.Cell Metab. 2021 Oct 5;33(10):1926-1942.e8. doi: 10.1016/j.cmet.2021.06.014. Epub 2021 Jul 15. Cell Metab. 2021. PMID: 34270930
References
-
- Knauf F, Brewer JR, and Flavell RA (2019). Immunity, microbiota and kidney disease. Nat. Rev. Nephrol 15, 263–274. - PubMed
-
- Koppe L, Mafra D, and Fouque D (2015). Probiotics and chronic kidney disease. Kidney Int. 88, 958–966. - PubMed
-
- Lempert KD (2019). Probiotics and CKD progression: are creatinine-based estimates of GFR applicable? Am. J. Kidney Dis. 74, 429–431. - PubMed
-
- Simic P, Vela Parada XF, Parikh SM, Dellinger R, Guarente LP, and Rhee EP (2020). Nicotinamide riboside with pterostilbene (NRPT) increases NAD+ in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI. BMC Nephrol. 21, 342. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
